For the quarter ending 2025-09-30, RLAY has $670,000K in assets. $62,291K in debts. $91,564K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 91,564 | 113,941 | ||
| Investments | 504,867 | 542,834 | ||
| Prepaid expenses | 23,839 | 16,040 | ||
| Other current assets | 3,744 | 7,577 | ||
| Total current assets | 624,014 | 680,392 | ||
| Property and equipment, net | 2,359 | 3,461 | ||
| Operating lease assets | 41,369 | 42,730 | ||
| Restricted cash | 2,258 | 2,258 | ||
| Intangible asset | 0 | 0 | ||
| Total assets | 670,000 | 728,841 | ||
| Accounts payable | 2,752 | 5,176 | ||
| Accrued expenses | 25,132 | 23,215 | ||
| Operating lease liabilities | 3,643 | 3,525 | ||
| Other current liabilities | 1,078 | 609 | ||
| Total current liabilities | 32,605 | 32,525 | ||
| Operating lease liabilities, net of current portion | 29,686 | 30,658 | ||
| Total liabilities | 62,291 | 63,183 | ||
| Common stock, 0.001 par value 300,000,000 shares authorized as of september 30, 2025, and december 31, 2024 172,631,268 and 167,755,715 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 168 | 168 | ||
| Additional paid-in capital | 2,566,927 | 2,551,383 | ||
| Accumulated other comprehensive gain (loss) | 493 | -163 | ||
| Accumulated deficit | -1,959,879 | -1,885,730 | ||
| Total stockholders' equity | 607,709 | 665,658 | ||
| Total liabilities and stockholders' equity | 670,000 | 728,841 | ||
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)